Arbutus Biopharma (ABUS) Institutional Ownership

$3.42 -0.02 (-0.49%)

Closing price 02/21/2025 03:59 PM Eastern

Extended Trading

$3.45 +0.03 (+0.76%)

As of 02/21/2025 06:26 PM Eastern

Compare

Current Institutional Ownership Percentage: 43.79%
Number of Institutional Buyers (last 12 months): 64
Total Institutional Inflows (last 12 months): $38.93M

Number of Institutional Sellers (last 12 months): 25
Total Institutional Outflows (last 12 months): $11.54M

Get ABUS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arbutus Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/18/2025	Two Seas Capital LP	8,740,956	$28.58M	2.2%	+4.2%	4.613%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	103,943	$340K	0.0%	-46.9%	0.055%
2/17/2025	Whitefort Capital Management LP	13,241,916	$43.30M	20.8%	+2.9%	6.988%
2/17/2025	Woodline Partners LP	971,628	$3.18M	0.0%	+45.4%	0.513%
2/17/2025	Saba Capital Management L.P.	887,993	$2.90M	0.1%	+31.3%	0.469%
2/17/2025	Rafferty Asset Management LLC	146,803	$480K	0.0%	+27.6%	0.077%
2/17/2025	ProShare Advisors LLC	50,121	$164K	0.0%	+29.3%	0.026%
2/17/2025	Millennium Management LLC	343,028	$1.12M	0.0%	+36.7%	0.181%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	89,397	$292K	0.0%	+10.2%	0.047%
2/17/2025	LMR Partners LLP	158,249	$517K	0.0%	-19.7%	0.084%
Get the Latest News and Ratings for ABUS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter.
2/17/2025	Hudson Bay Capital Management LP	1,112,500	$3.64M	0.0%	+8.0%	0.587%
2/17/2025	Deutsche Bank AG	171,766	$562K	0.0%	+77.9%	0.091%
2/17/2025	Balyasny Asset Management L.P.	41,690	$136K	0.0%	N/A	0.022%
2/17/2025	Bank of America Corp DE	361,304	$1.18M	0.0%	+90.8%	0.191%
2/17/2025	BNP Paribas Financial Markets	247,996	$811K	0.0%	-19.1%	0.131%
2/17/2025	Ameriprise Financial Inc.	18,917	$62K	0.0%	N/A	0.010%
2/14/2025	Mercer Global Advisors Inc. ADV	20,500	$67K	0.0%	N/A	0.011%
2/14/2025	Northern Trust Corp	1,330,683	$4.35M	0.0%	+8.3%	0.702%
2/14/2025	Boothbay Fund Management LLC	162,277	$531K	0.0%	-73.5%	0.086%
2/14/2025	Susquehanna Fundamental Investments LLC	202,541	$662K	0.0%	N/A	0.107%
2/14/2025	Virtus ETF Advisers LLC	19,970	$65K	0.0%	-31.5%	0.011%
2/14/2025	Two Sigma Securities LLC	19,475	$64K	0.0%	N/A	0.010%
2/14/2025	Two Seas Capital LP	8,740,956	$28.58M	2.5%	+4.2%	4.613%
2/14/2025	Adage Capital Partners GP L.L.C.	1,650,941	$5.40M	0.0%	-43.1%	0.871%
2/14/2025	Price T Rowe Associates Inc. MD	56,452	$185K	0.0%	+18.1%	0.030%
2/14/2025	BlackBarn Capital Partners LP	2,341,871	$7.66M	0.4%	+13.1%	1.236%
2/14/2025	Hsbc Holdings PLC	16,994	$55K	0.0%	N/A	0.009%
2/13/2025	XTX Topco Ltd	52,581	$172K	0.0%	+75.2%	0.028%
2/13/2025	Barclays PLC	298,253	$975K	0.0%	+9.6%	0.157%
2/13/2025	Rockefeller Capital Management L.P.	106,615	$349K	0.0%	+69.2%	0.056%
2/13/2025	Quinn Opportunity Partners LLC	404,879	$1.32M	0.1%	+72.2%	0.214%
2/13/2025	Raymond James Financial Inc.	10,504	$34K	0.0%	N/A	0.006%
2/13/2025	Legal & General Group Plc	118,693	$388K	0.0%	-18.6%	0.063%
2/13/2025	Invesco Ltd.	69,831	$228K	0.0%	+5.7%	0.037%
2/13/2025	ADAR1 Capital Management LLC	1,554,802	$5.08M	1.0%	-25.6%	0.821%
2/13/2025	Bank of Montreal Can	455,880	$1.49M	0.0%	+3.5%	0.241%
2/13/2025	Wells Fargo & Company MN	70,599	$231K	0.0%	+44.6%	0.037%
2/12/2025	Rangeley Capital LLC	1,459,000	$4.77M	4.3%	N/A	0.770%
2/12/2025	Geode Capital Management LLC	3,482,136	$11.39M	0.0%	+1.0%	1.838%
2/12/2025	Franklin Resources Inc.	92,159	$301K	0.0%	N/A	0.049%
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th.
2/12/2025	Alliancebernstein L.P.	120,240	$393K	0.0%	-12.6%	0.063%
2/12/2025	Wellington Management Group LLP	513,302	$1.68M	0.0%	+3.3%	0.271%
2/12/2025	JPMorgan Chase & Co.	896,258	$2.93M	0.0%	+900.4%	0.473%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	69,660	$238K	0.0%	-15.0%	0.037%
2/11/2025	Corebridge Financial Inc.	72,632	$238K	0.0%	-7.0%	0.038%
2/11/2025	Vanguard Group Inc.	8,980,864	$29.37M	0.0%	+0.7%	4.739%
2/11/2025	KLP Kapitalforvaltning AS	25,600	$84K	0.0%	N/A	0.014%
2/11/2025	Corbin Capital Partners L.P.	682,487	$2.23M	3.7%	-20.0%	0.360%
2/11/2025	Teacher Retirement System of Texas	42,144	$138K	0.0%	+18.7%	0.022%
2/11/2025	Xponance Inc.	10,486	$34K	0.0%	N/A	0.006%
2/11/2025	Intech Investment Management LLC	57,084	$187K	0.0%	+54.9%	0.030%
2/10/2025	Cibc World Markets Corp	13,672	$45K	0.0%	N/A	0.007%
2/7/2025	E Fund Management Co. Ltd.	10,385	$34K	0.0%	N/A	0.005%
2/6/2025	Raymond James Financial Inc.	10,504	$34K	0.0%	N/A	0.006%
2/6/2025	Charles Schwab Investment Management Inc.	1,222,201	$4.00M	0.0%	+0.8%	0.645%
2/6/2025	SBI Securities Co. Ltd.	72,280	$236K	0.0%	N/A	0.038%
2/5/2025	Verus Capital Partners LLC	19,350	$63K	0.0%	-28.1%	0.010%
1/30/2025	Rhumbline Advisers	188,598	$617K	0.0%	+6.0%	0.100%
1/24/2025	China Universal Asset Management Co. Ltd.	40,179	$131K	0.0%	+10.7%	0.021%
1/22/2025	PFG Investments LLC	14,200	$46K	0.0%	-26.0%	0.007%
1/17/2025	SG Americas Securities LLC	69,119	$226K	0.0%	+30.7%	0.036%
1/17/2025	Clear Harbor Asset Management LLC	79,761	$261K	0.0%	+6.7%	0.042%
1/16/2025	Ballentine Partners LLC	31,121	$102K	0.0%	N/A	0.016%
12/26/2024	JPMorgan Chase & Co.	89,586	$345K	0.0%	+11.0%	0.047%
12/19/2024	Principal Financial Group Inc.	13,755	$53K	0.0%	-47.3%	0.007%
11/19/2024	Barclays PLC	272,029	$1.05M	0.0%	+466.3%	0.144%
11/16/2024	Geode Capital Management LLC	3,448,600	$13.28M	0.0%	+4.1%	1.820%
11/15/2024	Barclays PLC	272,029	$1.05M	0.0%	+466.3%	0.144%
11/15/2024	XTX Topco Ltd	30,013	$116K	0.0%	+76.2%	0.016%
11/15/2024	Jane Street Group LLC	66,910	$258K	0.0%	-67.1%	0.035%
11/15/2024	Wellington Management Group LLP	496,818	$1.91M	0.0%	+4.6%	0.262%
11/15/2024	State Street Corp	4,407,133	$16.97M	0.0%	+50.2%	2.326%
11/15/2024	Janus Henderson Group PLC	60,900	$234K	0.0%	N/A	0.032%
11/15/2024	Centiva Capital LP	40,000	$154K	0.0%	-24.2%	0.021%
11/14/2024	Rockefeller Capital Management L.P.	63,000	$243K	0.0%	N/A	0.033%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	195,843	$754K	0.0%	N/A	0.103%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	37,503	$144K	0.0%	+453.1%	0.020%
11/13/2024	BNP Paribas Financial Markets	306,367	$1.18M	0.0%	-12.0%	0.162%
11/13/2024	FMR LLC	83,280	$321K	0.0%	-17.4%	0.044%
11/12/2024	Charles Schwab Investment Management Inc.	1,212,246	$4.67M	0.0%	+218.5%	0.640%
11/9/2024	Intech Investment Management LLC	36,852	$142K	0.0%	N/A	0.020%
11/7/2024	LMR Partners LLP	197,025	$759K	0.0%	-22.9%	0.104%
11/5/2024	Verus Capital Partners LLC	26,900	$104K	0.0%	-35.2%	0.014%
10/31/2024	Principal Financial Group Inc.	13,755	$53K	0.0%	-47.3%	0.007%
10/25/2024	China Universal Asset Management Co. Ltd.	36,309	$140K	0.0%	+63.8%	0.019%
10/24/2024	Clear Harbor Asset Management LLC	74,761	$288K	0.0%	-25.8%	0.040%
10/11/2024	Creative Planning	49,500	$191K	0.0%	+13.8%	0.026%
10/8/2024	Helen Stephens Group LLC	13,000	$50K	0.0%	N/A	0.007%
10/3/2024	SG Americas Securities LLC	52,869	$204K	0.0%	N/A	0.028%
8/15/2024	Susquehanna Fundamental Investments LLC	208,152	$643K	0.0%	+102.2%	0.110%
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th.
8/15/2024	The Manufacturers Life Insurance Company	57,323	$177K	0.0%	+7.9%	0.030%
8/14/2024	Bank of Montreal Can	354,813	$1.10M	0.0%	+6.1%	0.188%
8/14/2024	ProShare Advisors LLC	28,618	$88K	0.0%	-17.1%	0.015%
8/13/2024	Rubric Capital Management LP	1,681,090	$5.20M	0.1%	N/A	0.891%
8/12/2024	XTX Topco Ltd	17,038	$53K	0.0%	N/A	0.009%
8/8/2024	American Century Companies Inc.	18,486	$57K	0.0%	-85.4%	0.010%
8/7/2024	Cowen AND Company LLC	20,000	$62K	0.0%	-60.0%	0.011%
8/1/2024	Rhumbline Advisers	185,067	$572K	0.0%	+8.6%	0.098%
7/31/2024	nVerses Capital LLC	11,000	$34K	0.0%	N/A	0.006%
7/29/2024	Principal Financial Group Inc.	26,107	$81K	0.0%	-37.0%	0.014%

(Data available from 1/1/2016 forward)

ABUS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ABUS shares?: During the previous two years, 99 institutional investors and hedge funds held shares of Arbutus Biopharma. The most heavily invested institutionals were Arete Wealth Advisors LLC ($45.45B), Whitefort Capital Management LP ($43.30M), Vanguard Group Inc. ($29.37M), Two Seas Capital LP ($28.58M), State Street Corp ($16.97M), Geode Capital Management LLC ($11.39M), and BlackBarn Capital Partners LP ($7.66M).Learn more on ABUS's institutional investors.
What percentage of Arbutus Biopharma stock is owned by institutional investors?: 43.79% of Arbutus Biopharma stock is owned by institutional investors. Learn more on ABUS's institutional investor holdings.
Which institutional investors have been buying Arbutus Biopharma stock?: Of the 75 institutional investors that purchased Arbutus Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Whitefort Capital Management LP ($4.02M), Rubric Capital Management LP ($2.41M), Hudson Bay Capital Management LP ($1.50M), State Street Corp ($1.47M), Rangeley Capital LLC ($1.46M), Charles Schwab Investment Management Inc. ($841.62K), and JPMorgan Chase & Co. ($815.53K).

How much institutional buying is happening at Arbutus Biopharma?: Institutional investors have bought a total of 19,142,728 shares in the last 24 months. This purchase volume represents approximately $59.55M in transactions.
Which Arbutus Biopharma major shareholders have been selling company stock?: Of the 36 institutional investors that sold Arbutus Biopharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.25M), Rubric Capital Management LP ($799.22K), ETF Managers Group LLC ($588.01K), ADAR1 Capital Management LLC ($534.52K), Boothbay Fund Management LLC ($450K), Whitefort Capital Management LP ($334.91K), and FourWorld Capital Management LLC ($251.06K).
How much institutional selling is happening at Arbutus Biopharma?: Institutional investors have sold a total of 5,449,248 shares in the last 24 months. This volume of shares sold represents approximately $16.39M in transactions.

Related Companies

This page (NASDAQ:ABUS) was last updated on 2/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arbutus Biopharma (ABUS) Institutional Ownership

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

ABUS Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arbutus Biopharma (ABUS) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Arbutus Biopharma (NASDAQ:ABUS)

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

ABUS Institutional Ownership - Frequently Asked Questions

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools